site stats

Astellas mycamine

WebMYCAMINE is contraindicated in persons with known hypersensitivity to micafungin sodium, any component of MYCAMINE, or other echinocandins. (4) WARNINGS AND PRECAUTIONS • • • • • ADVERSE REACTIONS • • To report SUSPECTED ADVERSE REACTIONS, contact Astellas Pharma US, Inc. at 1-800-727-7003 or FDA at 1-800-FDA … WebJan 23, 2024 · Astellas Transfers MYCAMINE® Product Worldwide. Published: Jan 23, 2024. TOKYO, Jan. 23, 2024 /PRNewswire/ -- Astellas Pharma US, Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that Astellas and Sandoz AG ("Sandoz") have entered into an Asset Purchase Agreement, under which …

Mycamine European Medicines Agency

WebJan 24, 2024 · Astellas reported Mycamine ® sales of JPY 18.9 billion (USD 135 million) for the year ending March 31, 2024. The announcement comes after Sandoz successfully completed the acquisition of GSK’s global cephalosporins portfolio in October 2024. WebAstellas Pharma US, Inc. announced today the availability of their antifungal agent MYCAMINE® (micafungin sodium) for injection in a 100mg vial format. Approved in 2005 … tamansh eye foundation https://aweb2see.com

DailyMed - MICAFUNGIN- micafungin sodium injection, powder, lyophilized ...

WebDec 15, 2014 · PHILADELPHIA – Pharmaceutical company Astellas Pharma US, Inc., will pay $7.3 million to resolve allegations that it violated the False Claims Act in connection with its marketing and promoting of the drug Mycamine for pediatric use. The settlement was announced today by United States Attorney Zane David Memeger and the Justice … WebJan 28, 2024 · FDA Approved: Yes (First approved March 16, 2005) Brand name: Mycamine. Generic name: micafungin sodium. Dosage form: for Injection. Company: Astellas Pharma US, Inc. Treatment for: Esophageal Candidiasis, Fungal Infection Prophylaxis, Candidemia. Mycamine (micafungin sodium) is an echinocandin antifungal … WebJun 24, 2013 · Astellas Pharma US, Inc., located in Northbrook, Illinois, is a U.S. affiliate of Tokyo -based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of... tws g273

Mycamine European Medicines Agency

Category:Astellas Pharma US, Inc. MYCAMINE- micafungin sodium

Tags:Astellas mycamine

Astellas mycamine

Astellas Pharma US, Inc. Announces Availability of MYCAMINE® …

WebMycamine: Astellas: Micafungin: Apotex: Used to treat candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, as well as esophageal candidiasis, and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation: WebMar 31, 2024 · Mycamine is indicated for: Adults, adolescents ≥ 16 years of age and elderly treatment of invasive candidiasis; treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate;

Astellas mycamine

Did you know?

WebJan 23, 2024 · MYCAMINE ® (Generic Name: micafungin sodium/product name in Japan: FUNGUARD ®) Sales of the product JPY 18.9 billion (fiscal year ended March 31, 2024) Astellas is reviewing potential... WebJan 23, 2024 · MYCAMINE ®. (Generic Name: micafungin sodium/product name in Japan: FUNGUARD ®) Sales of the product. JPY 18.9 billion (fiscal year ended March 31, 2024) Astellas is reviewing potential financial …

WebMycamine® Micafungin Sodium 100 mg Injection Vial 10 mL Astellas Pharma 00469321110. McKesson Shop Products Shop by Category ... Mycamine® Manufacturer: Astellas Pharma: Country of Origin: Unknown: Alternate Manufacturer Number: 1827963: Application: Antifungal: Container Type: Vial: Dosage Form: Injection: Generic Drug Code:

WebJan 24, 2024 · Astellas reported Mycamine ® sales of JPY 18.9 billion (USD 135 million) for the year ending March 31, 2024. The announcement comes after Sandoz successfully … WebJan 23, 2024 · MYCAMINE ® (Generic Name: micafungin sodium/product name in Japan: FUNGUARD ®) Sales of the product JPY 18.9 billion (fiscal year ended March 31, 2024) …

WebJan 23, 2024 · MYCAMINE ® (Generic Name: micafungin sodium/product name in Japan: FUNGUARD ®) Sales of the product JPY 18.9 billion (fiscal year ended March 31, 2024) Astellas is reviewing potential...

WebJan 24, 2024 · Astellas reported Mycamine ® sales of JPY 18.9 billion (USD 135 million) for the year ending March 31, 2024. The announcement comes after Sandoz successfully … tam ansbachWebJan 10, 2024 · Mycamine is an antifungal medication that fights infections caused by fungus. Mycamine is used to treat infections caused by the Candida fungus. It is also used to prevent Candida fungal infections in stem cell transplant patients. Mycamine is for use in adults and pediatric patients. tws-g273WebMar 4, 2024 · Additional pediatric use information is approved for Astellas Pharma US, Inc.'s Mycamine ® (micafungin for injection). However, due to Astellas Pharma US, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. 12.4 Microbiology Mechanism of Action. taman selera pj old townWeb3 . Background Drug Information: Mycamine (micafungin) • Therapeutic Category: echinocandin • Sponsor: Astellas Pharma, Inc. • Indication: In adults and pediatric patients 4 months tws-g273 説明書WebJan 24, 2024 · Astellas reported Mycamine sales of $135 million for the year ending Mar 31, 2024. Shares of Novartis have gained 7.7% in the past year compared with the … tamans online groceryWebeffectiveness of MYCAMINE in patients younger than four months of age have not been established. The overall safety of MYCAMINE was assessed in 479 patients, ages three days through 16 years, who received at least one dose of MYCAMINE in 11 separate clinical trials. The mean treatment duration was 24.8 days. tws g273 取説WebAstellas Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved their Supplemental New Drug Application (sNDA) seeking approval for the use of MYCAMINE® (micafungin sodium) for Injection in the treatment of patients with Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses. tws g273 説明書